1. Home
  2. LNTH vs CNK Comparison

LNTH vs CNK Comparison

Compare LNTH & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • CNK
  • Stock Information
  • Founded
  • LNTH 1956
  • CNK 1984
  • Country
  • LNTH United States
  • CNK United States
  • Employees
  • LNTH N/A
  • CNK N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CNK Movies/Entertainment
  • Sector
  • LNTH Health Care
  • CNK Consumer Discretionary
  • Exchange
  • LNTH Nasdaq
  • CNK Nasdaq
  • Market Cap
  • LNTH 3.6B
  • CNK 3.2B
  • IPO Year
  • LNTH 2015
  • CNK 2007
  • Fundamental
  • Price
  • LNTH $58.21
  • CNK $26.56
  • Analyst Decision
  • LNTH Strong Buy
  • CNK Buy
  • Analyst Count
  • LNTH 6
  • CNK 13
  • Target Price
  • LNTH $105.50
  • CNK $33.46
  • AVG Volume (30 Days)
  • LNTH 2.5M
  • CNK 4.7M
  • Earning Date
  • LNTH 08-06-2025
  • CNK 08-01-2025
  • Dividend Yield
  • LNTH N/A
  • CNK 1.21%
  • EPS Growth
  • LNTH N/A
  • CNK 86.03
  • EPS
  • LNTH 3.77
  • CNK 1.92
  • Revenue
  • LNTH $1,520,653,000.00
  • CNK $3,217,300,000.00
  • Revenue This Year
  • LNTH $4.57
  • CNK $7.95
  • Revenue Next Year
  • LNTH $9.41
  • CNK $7.50
  • P/E Ratio
  • LNTH $15.42
  • CNK $13.81
  • Revenue Growth
  • LNTH 5.75
  • CNK 13.80
  • 52 Week Low
  • LNTH $47.25
  • CNK $23.12
  • 52 Week High
  • LNTH $118.21
  • CNK $36.28
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 40.12
  • CNK 46.16
  • Support Level
  • LNTH $55.00
  • CNK $25.04
  • Resistance Level
  • LNTH $56.16
  • CNK $26.99
  • Average True Range (ATR)
  • LNTH 2.52
  • CNK 0.73
  • MACD
  • LNTH 0.57
  • CNK 0.27
  • Stochastic Oscillator
  • LNTH 41.41
  • CNK 82.01

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.

Share on Social Networks: